Literature DB >> 34396783

Chronic high-fat feeding and prolonged fasting in liver-specific ANGPTL4 knockout mice.

Kathryn M Spitler1, Shwetha K Shetty1, Emily M Cushing1, Kelli L Sylvers-Davie1, Brandon S J Davies1.   

Abstract

Obesity is associated with dyslipidemia, ectopic lipid deposition, and insulin resistance. In mice, the global or adipose-specific loss of function of the protein angiopoietin-like 4 (ANGPTL4) leads to decreased plasma triglyceride levels, enhanced adipose triglyceride uptake, and protection from high-fat diet (HFD)-induced glucose intolerance. ANGPTL4 is also expressed highly in the liver, but the role of liver-derived ANGPTL4 is unclear. The goal of this study was to determine the contribution of hepatocyte ANGPTL4 to triglyceride and glucose homeostasis in mice during a high-fat diet challenge. We generated hepatocyte-specific ANGPTL4 deficient (Angptl4LivKO) mice, fed them a 60% kcal/fat diet (HFD) for 6 mo and assessed triglyceride, liver, and glucose metabolic phenotypes. We also explored the effects of prolonged fasting on Angptl4LivKO mice. The loss of hepatocyte-derived ANGPTL4 led to no major changes in triglyceride partitioning or lipoprotein lipase activity compared with control mice. Interestingly, although there was no difference in fasting plasma triglyceride levels after a 6 h fast, after an 18-h fast, normal chow diet-fed Angptl4LivKO mice had lower triglyceride levels than control mice. On a HFD, Angptl4LivKO mice initially showed no difference in glucose tolerance and insulin sensitivity, but improved glucose tolerance emerged in these mice after 6 mo on HFD. Our data suggest that hepatocyte ANGPTL4 does not directly regulate triglyceride partitioning, but that loss of liver-derived ANGPTL4 may be protective from HFD-induced glucose intolerance and influence plasma triglyceride (TG) metabolism during prolonged fasting.NEW & NOTEWORTHY1) Angiopoietin-like 4 deficiency in hepatocytes (Angptl4LivKO) does not improve triglyceride phenotypes during high-fat feeding. 2) Angptl4LivKO mice have improved glucose tolerance after chronic high-fat diet. 3) Angptl4LivKO mice have decreased fasting plasma triglyceride levels after an 18-h fast, but not after a 6-h fast.

Entities:  

Keywords:  fasting; high-fat diet; lipoprotein lipase; lipoprotein metabolism; triglyceride

Mesh:

Substances:

Year:  2021        PMID: 34396783      PMCID: PMC8560380          DOI: 10.1152/ajpendo.00144.2021

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   5.900


  40 in total

1.  Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.

Authors:  C Postic; M Shiota; K D Niswender; T L Jetton; Y Chen; J M Moates; K D Shelton; J Lindner; A D Cherrington; M A Magnuson
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

2.  Angiopoietin-like 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes.

Authors:  Nora E Gray; Lily N Lam; Karen Yang; Anna Y Zhou; Suneil Koliwad; Jen-Chywan Wang
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

3.  Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.

Authors:  Anja Köster; Y Bernice Chao; Marian Mosior; Amy Ford; Patricia A Gonzalez-DeWhitt; John E Hale; Deshan Li; Yubin Qiu; Christopher C Fraser; Derek D Yang; Josef G Heuer; S Richard Jaskunas; Patrick Eacho
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

4.  Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice.

Authors:  Antwi-Boasiako Oteng; Philip M M Ruppert; Lily Boutens; Wieneke Dijk; Xanthe A M H van Dierendonck; Gunilla Olivecrona; Rinke Stienstra; Sander Kersten
Journal:  J Lipid Res       Date:  2019-08-13       Impact factor: 5.922

5.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.

Authors:  Stefano Romeo; Len A Pennacchio; Yunxin Fu; Eric Boerwinkle; Anne Tybjaerg-Hansen; Helen H Hobbs; Jonathan C Cohen
Journal:  Nat Genet       Date:  2007-02-25       Impact factor: 38.330

6.  Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.

Authors:  Frederick E Dewey; Viktoria Gusarova; Colm O'Dushlaine; Omri Gottesman; Jesus Trejos; Charleen Hunt; Cristopher V Van Hout; Lukas Habegger; David Buckler; Ka-Man V Lai; Joseph B Leader; Michael F Murray; Marylyn D Ritchie; H Lester Kirchner; David H Ledbetter; John Penn; Alexander Lopez; Ingrid B Borecki; John D Overton; Jeffrey G Reid; David J Carey; Andrew J Murphy; George D Yancopoulos; Aris Baras; Jesper Gromada; Alan R Shuldiner
Journal:  N Engl J Med       Date:  2016-03-02       Impact factor: 91.245

7.  Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice.

Authors:  Abhishek K Singh; Balkrishna Chaube; Xinbo Zhang; Jonathan Sun; Kathryn M Citrin; Alberto Canfrán-Duque; Binod Aryal; Noemi Rotllan; Luis Varela; Richard G Lee; Tamas L Horvath; Nathan Price; Yajaira Suárez; Carlos Fernandez-Hernando
Journal:  J Clin Invest       Date:  2021-07-13       Impact factor: 14.808

8.  Brown adipose tissue derived ANGPTL4 controls glucose and lipid metabolism and regulates thermogenesis.

Authors:  Abhishek K Singh; Binod Aryal; Balkrishna Chaube; Noemi Rotllan; Luis Varela; Tamas L Horvath; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Mol Metab       Date:  2018-03-29       Impact factor: 7.422

9.  Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.

Authors:  Aafke W F Janssen; Saeed Katiraei; Barbara Bartosinska; Daniel Eberhard; Ko Willems van Dijk; Sander Kersten
Journal:  Diabetologia       Date:  2018-03-03       Impact factor: 10.122

10.  Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.

Authors:  Viktoria Gusarova; Colm O'Dushlaine; Tanya M Teslovich; Peter N Benotti; Tooraj Mirshahi; Omri Gottesman; Cristopher V Van Hout; Michael F Murray; Anubha Mahajan; Jonas B Nielsen; Lars Fritsche; Anders Berg Wulff; Daniel F Gudbjartsson; Marketa Sjögren; Connor A Emdin; Robert A Scott; Wen-Jane Lee; Aeron Small; Lydia C Kwee; Om Prakash Dwivedi; Rashmi B Prasad; Shannon Bruse; Alexander E Lopez; John Penn; Anthony Marcketta; Joseph B Leader; Christopher D Still; H Lester Kirchner; Uyenlinh L Mirshahi; Amr H Wardeh; Cassandra M Hartle; Lukas Habegger; Samantha N Fetterolf; Teresa Tusie-Luna; Andrew P Morris; Hilma Holm; Valgerdur Steinthorsdottir; Patrick Sulem; Unnur Thorsteinsdottir; Jerome I Rotter; Lee-Ming Chuang; Scott Damrauer; David Birtwell; Chad M Brummett; Amit V Khera; Pradeep Natarajan; Marju Orho-Melander; Jason Flannick; Luca A Lotta; Cristen J Willer; Oddgeir L Holmen; Marylyn D Ritchie; David H Ledbetter; Andrew J Murphy; Ingrid B Borecki; Jeffrey G Reid; John D Overton; Ola Hansson; Leif Groop; Svati H Shah; William E Kraus; Daniel J Rader; Yii-Der I Chen; Kristian Hveem; Nicholas J Wareham; Sekar Kathiresan; Olle Melander; Kari Stefansson; Børge G Nordestgaard; Anne Tybjærg-Hansen; Goncalo R Abecasis; David Altshuler; Jose C Florez; Michael Boehnke; Mark I McCarthy; George D Yancopoulos; David J Carey; Alan R Shuldiner; Aris Baras; Frederick E Dewey; Jesper Gromada
Journal:  Nat Commun       Date:  2018-06-13       Impact factor: 14.919

View more
  1 in total

Review 1.  An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues.

Authors:  Ren Zhang; Kezhong Zhang
Journal:  Prog Lipid Res       Date:  2021-11-16       Impact factor: 16.195

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.